Tapewire

Nasdaq · USD

SWAG

Stran & Company, Inc.

Export transactions ↓
Tapewire entity
9074
SEC CIK
0001872525
Parsed reports
60

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 12, 2021 Filed Nov 16, 2021 19:33 UTC
Audibert JohnVP of Growth & Strat. Ini.
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059936 · ownership.xml · nonDerivative · entry 1

Audibert John · CIK 0001888617 · VP of Growth & Strat. Ini.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: Subject to vesting over a three (3) year period with one-third (1/3) of the restricted stock and options vesting on each of the first, second and third anniversaries of the date of grant.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:43 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059826 · ownership.xml · derivative · entry 2

Tani Alejandro · CIK 0001888592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2031-11-11

F2 · derivative.exercise_date: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:43 UTC GrantCommon Stock 2,892 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059826 · ownership.xml · nonDerivative · entry 1

Tani Alejandro · CIK 0001888592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

F1 · security: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:42 UTC
Stranberg AndrewDirector · EC, Treasurer & Sec. · 10% owner
GrantEmployee Stock Option (Right to Buy) · Derivative 400,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059824 · ownership.xml · derivative · entry 1

Stranberg Andrew · CIK 0001674997 · Director · EC, Treasurer & Sec. · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2031-11-11

F1 · derivative.exercise_date: The options vest over a four (4) year period with twenty-five percent (25%) vesting on the first anniversary of the date of grant and the balance (seventy-five percent (75%)) vesting monthly over the following three (3) years after the first anniversary of the date of grant at a rate of 1/36 per month.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:41 UTC
Shape AndrewDirector · President and CEO · 10% owner
GrantEmployee Stock Option (Right to Buy) · Derivative 323,810 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059822 · ownership.xml · derivative · entry 1

Shape Andrew · CIK 0001748801 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,810

Underlying: Common Stock · 323,810 shares

Expires 2031-11-11

F1 · derivative.exercise_date: The options vest over a four (4) year period with twenty-five percent (25%) vesting on the first anniversary of the date of grant and the balance (seventy-five percent (75%)) vesting monthly over the following three (3) years after the first anniversary of the date of grant at a rate of 1/36 per month.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:39 UTC
Rollins ChristopherChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 81,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059819 · ownership.xml · derivative · entry 2

Rollins Christopher · CIK 0001888612 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,000

Underlying: Common Stock · 81,000 shares

Expires 2031-11-11

F1 · derivative.exercise_date: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:39 UTC
Rollins ChristopherChief Financial Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059819 · ownership.xml · nonDerivative · entry 1

Rollins Christopher · CIK 0001888612 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:38 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059817 · ownership.xml · derivative · entry 2

McCourt Travis · CIK 0001890270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2031-11-11

F2 · derivative.exercise_date: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:38 UTC GrantCommon Stock 2,892 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059817 · ownership.xml · nonDerivative · entry 1

McCourt Travis · CIK 0001890270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

F1 · security: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:36 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059814 · ownership.xml · derivative · entry 2

Marshall Ashley · CIK 0001888970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2031-11-11

F2 · derivative.exercise_date: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:36 UTC GrantCommon Stock 2,892 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059814 · ownership.xml · nonDerivative · entry 1

Marshall Ashley · CIK 0001888970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

F1 · security: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:35 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059809 · ownership.xml · derivative · entry 2

Chippindale Alan · CIK 0001888945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2031-11-11

F2 · derivative.exercise_date: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:35 UTC GrantCommon Stock 2,892 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-059809 · ownership.xml · nonDerivative · entry 1

Chippindale Alan · CIK 0001888945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

F1 · security: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 15:34 UTC
Birney RandolphExecutive Vice President
GrantEmployee Stock Option (Right to Buy) · Derivative 76,190 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001213900-21-059806 · ownership.xml · derivative · entry 1

Birney Randolph · CIK 0001888622 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,190

Underlying: Common Stock · 76,190 shares

Expires 2031-11-11

F1 · derivative.exercise_date: Vest over a four (4) year period with twenty-five percent (25%) of the options vesting on the first anniversary of the date of grant and the balance of the options (seventy-five percent (75%)) vest monthly over the following three (3) years after the first anniversary of the date of grant at a rate of 1/36 per month.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.